Journal Article Randomized Controlled Trial Clinical Trial, Phase II Ppublish
PubMed: 40173094 DOI: 10.2337/db25-0096
A Randomized Controlled, Double-Masked, Crossover Study of a GPR119 Agonist on Glucagon Counterregulation During Hypoglycemia in Type 1 Diabetes.
Diabetes 74(7):1262-1272
Authors: Anika Bilal, Anna Casu, Fanchao Yi, Tumpa Dutta, Justine M Mucinski, Gina Mercouffer, Martin C Marak, Marcus Hompesch, David Kelley, Richard E Pratley
Affiliations
- AdventHealth Translational Research Institute, Orlando, FL.
- Jaeb Center for Health Research, Tampa, FL.
- ProSciento, Inc. San Diego, CA.
- Cardiometabolic Diseases, Merck Research Laboratories, Rahway, NJ.
- AdventHealth Diabetes Institute, Orlando, FL.
MeSH
Diabetes Mellitus, Glucagon-Like Peptide 1, Cells, Islets Of Langerhans, Cross-Over Studies, Epinephrine, Glucagon, Therapeutics, Hypoglycemia, Diabetes Mellitus, Type 1